Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenoviridae Infections × 30 days × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 77 Neoplasm Metastasis 68 Leukemia, Myeloid, Acute 63 Neoplasms 61 Colorectal Neoplasms 59 Breast Neoplasms 46 Recurrence 36 Melanoma 36 Lung Neoplasms 36 Prostatic Neoplasms 35 Ovarian Neoplasms 35 Multiple Myeloma 34 Glioblastoma 31 Glioma 28 Triple Negative Breast Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 27 Myelodysplastic Syndromes 27 Lymphoma, Non-Hodgkin 27 Pancreatic Neoplasms 26 Endometrial Neoplasms 26 Brain Neoplasms 21 Small Cell Lung Carcinoma 19 Sarcoma 19 Lymphoma, Large B-Cell, Diffuse 19 Carcinoma, Hepatocellular 19 Urinary Bladder Neoplasms 18 Stomach Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, B-Cell 18 Lymphoma 18

Interventions

Tumor Necrosis Factor-alpha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡